Dr. Shengxiang Ren is an associate professor at Shanghai Pulmonary Hospital, Tongji University and Vice Director at Shanghai Pulmonary Hospital. He is a vice header of interventional section in the […] Read more
PROVIDER RESOURCES
MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC
INDUSTRY SUPPORTED
COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events